DTX401

· Ultragenyx Pharmaceutical Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DTX401, covering 2022-11-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of Long-Term Safety and Efficacy on Gene Therapy in Glycogen Storage Disease Type Ia